This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Astrazeneca Ab. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Anders Holmgren - Innovator in Pharmaceutical Formulations
Introduction
Anders Holmgren is a notable inventor based in Södertälje, Sweden. He is currently associated with AstraZeneca AB, where he contributes to the field of pharmaceutical formulations. Despite having no granted patents, his work in developing innovative solid pharmaceutical formulations is significant.
Latest Patent Applications
Anders Holmgren's recent patent application focuses on "Solid Pharmaceutical Formulations of 6-(2-Chloro-6-Methylpyridin-4-Yl)-5-(4-Fluorophenyl)-1,2,4-Triazine-3-Amine." This application describes solid formulations that include a polymeric stabilizer, such as polyvinylpyrrolidone, an ionic surfactant like sodium docusate, and a non-ionic surfactant such as poloxamer. These formulations aim to enhance the stability and efficacy of the pharmaceutical compound AZD4635.
Conclusion
Anders Holmgren's contributions to pharmaceutical innovations reflect his dedication to advancing medical science, even in the absence of granted patents. His work continues to influence the development of effective treatments in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile